Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Charles A Stiller"'
Autor:
Charles A. Stiller, Kathryn J. Bunch, Anita M. Bayne, Michael C. G. Stevens, Michael F. G. Murphy
Publikováno v:
Pediatric Blood & Cancer. 70
Autor:
Hanhua Liu, Charles A. Stiller, Colin J. Crooks, Brian Rous, Mary Bythell, John Broggio, Judith Rankin, Vasanta Nanduri, Peter Lanyon, Tim R. Card, Lu Ban, Lucy Elliss‐Brookes, Jennifer M. Broughan, Lizz Paley, Kwok Wong, Andrew Bacon, Mark Bishton, Joe West
Publikováno v:
British journal of haematologyREFERENCES. 199(5)
This analysis is the largest population-based study to date to provide contemporary and comprehensive epidemiological estimates of all third edition of the International Classification of Diseases for Oncology (ICD-O-3) coded Langerhans cell histiocy
Autor:
Fahmina Fardus-Reid, Lorna A Fern, Kathy Pritchard-Jones, Alison Cameron, Martin G. McCabe, Richard G. Feltbower, Lucy Irvine, Lucy Elliss-Brookes, Jon Shelton, Charles A. Stiller, Jess Fraser
Publikováno v:
Fraser, J, Fardus-Reid, F, Irvine, L, Elliss-Brookes, L, Fern, L, Cameron, A L, Pritchard-Jones, K, Feltbower, R G, Shelton, J, Stiller, C & McCabe, M G 2021, ' Oral etoposide as a single agent in childhood and young adult cancer in England : Still a poorly evaluated palliative treatment ', Pediatric Blood & Cancer, pp. e29204 . https://doi.org/10.1002/pbc.29204
BACKGROUND: Oral etoposide is commonly used in palliative treatment of childhood and young adult cancer without robust evidence. We describe a national, unselected cohort of young people in England treated with oral etoposide using routinely collecte
Autor:
Richard J. England, Charles A. Stiller, Anna Kelsey, Nadeem Haider, Gordan M. Vujanic, Kathy Pritchard-Jones, Mark Powis
Publikováno v:
Pediatric Blood & Cancer. 56:744-748
Background. Mesoblastic nephroma (MN) is a rare tumour which occurs mainly in early infancy and for which primary nephrectomy is the treatment of choice. This study aimed to assess surgical complications and outcomes in this patient group and to re-e
Publikováno v:
Pediatric Blood & Cancer. 55:85-90
Background The analysis of a contemporary multi-centre series of synovial sarcoma in children and young people describes the clinical characteristics, examines the effect of known prognostic factors and looks at outcome with particular emphasis on a
Autor:
Charles A. Stiller, Pat A. Brownbill, Judith M. Chessells, Ian Hann, Helena Kempski, S. Jane Passmore
Publikováno v:
British Journal of Haematology. 121:758-767
We aimed to identify and classify cases of paediatric myelodysplastic syndromes (MDS) occurring in Britain to estimate the incidence of this rare group of diseases, investigate the results of therapy and identify prognostic risk factors. Patients age
Autor:
Ray A. Cartwright, S. J. Proctor, Sylvia Benjamin, P. R. A. Taylor, J. A. Whittaker, J. V. Clough, Keith Wheatley, J. R. Y. Ross, M E Kroll, D. W. Gorst, Charles A. Stiller
Publikováno v:
British Journal of Haematology. 111:1045-1050
Approaches to the management of adolescents and young adults with acute leukaemia were investigated by sending a questionnaire to hospitals identified as having diagnosed or treated patients aged 15-29 years. The responses demonstrated the types of h
Autor:
D. W. Gorst, Keith Wheatley, Ray A. Cartwright, J. V. Clough, Charles A. Stiller, M E Kroll, J. R. Y. Ross, P. R. A. Taylor, Sylvia Benjamin, S. J. Proctor, J. A. Whittaker
Publikováno v:
British Journal of Haematology. 111:1045-1050
Autor:
Sanjay Tewari, Charles A. Stiller, Komel Khabra, Mary Taj, Donna Lancaster, Parameswaran Anoop, Sushama Sankpal
Publikováno v:
Leukemialymphoma. 53(10)
Patients with childhood relapsed and refractory mature B-cell non-Hodgkin lymphoma (B-NHL) and acute lymphoblastic leukemia (B-ALL) are rare and have a dismal prognosis. The previous UK national analysis of 26 children over a 7-year period prior to 1
Publikováno v:
Pediatric bloodcancer. 50(4)
Background Peripheral T-cell lymphomas (PTCL) are very rare in children and this has prevented assessment of best treatment and prognosis. Procedure Registry-based experience in England, Scotland and Wales over a 20-year period was studied to address